| The demographics of same-sex marriages in Norway and Sweden G Andersson, T Noack, A Seierstad, H Weedon-Fekjær Demography 43 (1), 79-98, 2006 | 398 | 2006 |
| Prediction of cancer incidence in the Nordic countries up to the year 2020 B Moller, H Fekjær, T Hakulinen, L Tryggvadóttir, HH Storm, M Talback, ... European Journal of Cancer Prevention 11, 2002 | 287 | 2002 |
| Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches B Møller, H Fekjær, T Hakulinen, H Sigvaldason, HH Storm, M Talbäck, ... Statistics in medicine 22 (17), 2751-2766, 2003 | 281 | 2003 |
| Breast cancer tumor growth estimated through mammography screening data H Weedon-Fekjær, BH Lindqvist, LJ Vatten, OO Aalen, S Tretli Breast Cancer Research 10, 1-13, 2008 | 223 | 2008 |
| Modern mammography screening and breast cancer mortality: population study H Weedon-Fekjær, PR Romundstad, LJ Vatten Bmj 348, 2014 | 210 | 2014 |
| Nationwide quality assurance of rectal cancer treatment A Wibe, E Carlsen, O Dahl, KM Tveit, H Weedon‐Fekjaer, UE Hestvik, ... Colorectal Disease 8 (3), 224-229, 2006 | 101 | 2006 |
| Covariate adjustment of event histories estimated from Markov chains: the additive approach OO Aalen, Ø Borgan, H Fekjær Biometrics 57 (4), 993-1001, 2001 | 98 | 2001 |
| The influence of mammographic screening on national trends in breast cancer incidence B Møller, H Weedon-Fekjaer, T Hakulinen, L Tryggvadottir, HH Storm, ... European Journal of Cancer Prevention 14 (2), 117-128, 2005 | 85 | 2005 |
| Dynamic analysis of multivariate failure time data OO Aalen, J Fosen, H Weedon-Fekjær, Ø Borgan, E Husebye Biometrics 60 (3), 764-773, 2004 | 79 | 2004 |
| The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age–period–cohort model RE Gangnon, BL Sprague, NK Stout, O Alagoz, H Weedon-Fekjær, ... Cancer Epidemiology, Biomarkers & Prevention 24 (6), 905-912, 2015 | 72 | 2015 |
| Increased risk for clinical onset of myasthenia gravis during the postpartum period MI Boldingh, AH Maniaol, C Brunborg, H Weedon-Fekjær, ... Neurology 87 (20), 2139-2145, 2016 | 71 | 2016 |
| Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use H Weedon-Fekjær, K Bakken, LJ Vatten, S Tretli Bmj 344, 2012 | 69 | 2012 |
| Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978–2010) O Solheim, DM Gershenson, CG Tropé, E Rokkones, CC Sun, ... European journal of cancer 50 (11), 1942-1950, 2014 | 68 | 2014 |
| Prognostic factors and treatment results of high-grade osteosarcoma in Norway: a scope beyond the “classical” patient K Berner, KS Hall, OR Monge, H Weedon-Fekjær, O Zaikova, ØS Bruland Sarcoma 2015, 2015 | 52 | 2015 |
| Dynamic analysis of recurrent event data using the additive hazard model J Fosen, Ø Borgan, H Weedon‐Fekjær, OO Aalen Biometrical Journal: Journal of Mathematical Methods in Biosciences 48 (3 …, 2006 | 51 | 2006 |
| Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results H Weedon-Fekjær, LJ Vatten, OO Aalen, B Lindqvist, S Tretli Journal of medical screening 12 (4), 172-178, 2005 | 47 | 2005 |
| A demographic analysis of registered partnerships (legal same-sex unions): The case of Norway T Noack, A Seierstad, H Weedon-Fekjær European Journal of Population/Revue européenne de Démographie 21, 89-109, 2005 | 47 | 2005 |
| High Norwegian prostate cancer mortality: evidence of over-reporting S Löffeler, A Halland, H Weedon-Fekjær, A Nikitenko, CL Ellingsen, ... Scandinavian journal of urology 52 (2), 122-128, 2018 | 41 | 2018 |
| Common model inputs used in CISNET collaborative breast cancer modeling JS Mandelblatt, AM Near, DL Miglioretti, D Munoz, BL Sprague, ... Medical Decision Making 38 (1_suppl), 9S-23S, 2018 | 40 | 2018 |
| Empirical evaluation of prediction intervals for cancer incidence B Møller, H Weedon-Fekjær, T Haldorsen BMC Medical Research Methodology 5, 1-9, 2005 | 38 | 2005 |
Ørnulf BorganProfessor of Statistics, University of Oslo, NorwayVerified email at math.uio.no
